Evaluation of rapid measurement of Chlamydia trachomatis and Neisseria gonorrhoeae by using automatic gene analyzer "GENECUBE".

Authors:
  • NMNarimi Miyazaki
    Narimi Miyazaki
  • YYYuka Yamagishi
    Yuka Yamagishi
  • KIKoji Izumi
    Koji Izumi
  • YKYosuke Kawashima
    Yosuke Kawashima
  • HSHiroyuki Suematsu
    Hiroyuki Suematsu
  • HMHiroshige Mikamo
    Hiroshige Mikamo

  • 1 August 2016
    • journal article
    • research article
Abstract
Nucleic acid amplification tests (NAATs) are considered as one of critical diagnostic methods on Chlamydia trachomatis and Neisseria gonorrhoeae infections due to their high sensitivity and accuracy. However, conventional NAATs required 2-6 hours to complete the measurements including extraction, amplification, and detection of the target nucleic acids. To reduce the time, we evaluated the clinical significance of the rapid NAAT using GENECUBE (TOYOBO CO., LTD.) which can complete the measurement within 1 hour. We compared the performance of GENECUBE with those of TMA method (APTIMA" Combo2 chlamydia/ gonorrhoeae, Hologic Japan, Inc.) and lateral flow immunochromatographic assay (Clearview Chlamydia, Clearview gonorrhoeae, Alere Medical Co., Ltd.) by detecting specimens from 96 cervical swabs. The overall agreement results between GENECUBE and TMA were 95.8% and 100% for C. trachomatis and N. gonorrhoeae, respectively. The results suggested that GENECUBE showed equivalent sensitivity and specificity of TMA. Indeed, more than half of the positive samples in NAATs were measured as negative in the lateral flow. The lateral flow is known as a rapid assay, however the results revealed its poor sensitivity. We think rapid NAATs using GENECUBE on C. trachomatis and N. gonorrhoeae can be one of the methods, which realize rapid tests with high sensitivity and accuracy.